Diagnostic value of molecular forms of prostate-specific antigen for female breast cancer

Clinical Biochemistry

Volumn 29, Issue 3, 1996, Pages 193-200

  Melegos, Dimitrios N ^b   Diamandis, Eleftherios P ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

^b NONE

Author keywords

breast cancer diagnosis; molecular forms of PSA; prostate specific antigen; PSA subfractions

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANTIGEN DETECTION; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOFLUORESCENCE TEST; MASTECTOMY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL;

EID: 0029925892     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/0009-9120(96)00014-E     Document Type: Article

References (21)

1. Armbruster DA. Prostate-specific antigen: biochemistry, analytical methods, and clinical application. Clin Chem 1993; 39: 181-95.
2. Oesterling JE. Prostate specific antigen: A critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 1991; 45: 907-23.
3. Van Krieken JH. Prostate marker immunoreactivity in salivary gland neoplasms. Am J Surg Pathol 1993; 17: 410-4.
4. Diamandis EP, Yu H, Sutherland DJA. Detection of prostate specific antigen immunoreactivity in breast tumors. Breast Cancer Res Treat 1994; 32: 301-10.
5. Levesque M, Yu H, D'Costa M, Tadross L, Diamandis EP. Immunoreactive prostate specific antigen in lung tumors. J Clin Lab Anal 1995; 9: 375-9.
6. Yu H, Diamandis EP. Prostate specific antigen in milk of lactating women. Clin Chem 1994; 41: 54-8.
7. Yu H, Diamandis EP, Monne M, Croce CM. Oral contraceptive-induced expression of prostate specific antigen in the female breast. J Biol Chem 1995; 270: 6615-8.
8. Yu H, Diamandis EP. Prostate specific antigen immunoreactivity in amniotic fluid. Clin Chem 1995; 41: 204-10.
9. Melegos DN, Yu H, Allen LC, Diamandis EP. Prostate specific antigen in amniotic fluid of normal and abnormal pregnancies. Clin Chem (submitted).
10. Monne M, Croce CM, Yu H, Diamandis EP. Molecular characterization of prostate specific antigen RNA expressed in breast tumor. Cancer Res 1994;54:6344-7.
11. Yu H, Diamandis EP, Sutherland DJA. Immunoreactive prostate specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient age. Clin Biochem 1994; 27: 75-9.
12. Yu H, Diamandis EP, Zarghami N, Grass L. Induction of prostate specific antigen production by steroids and tamoxifen in breast cancer cell lines. Breast Cancer Res Treat 1994;32:291-300.
13. 1-antichymotrypsin is the major form of prostate specific antigen in serum of patients with prostate cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res 1991; 51: 222-6.
14. Christensson A, Laurell CB, Lilja H. Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors. Eur J Biochem 1990; 194: 755-63.
15. Yu H, Diamandis EP. Measurement of serum prostate specific antigen levels in females and in prostatectomized males with an ultrasensitive immunoassay technique. J Urol 1995; 153: 1004-8.
16. Yu H, Giai M, Diamandis EP, Katsaros D, Sutherland DJA, Levesque MA, Roagna R, Ponzone R, Sismondi P. Prostate specific antigen is a new favourable prognostic indicator for women with breast cancer. Cancer Res 1995; 55: 2104-10.
17. Giai M, Yu H, Roagna R, Ponzone R, Katsaros D, Levesque MA, Diamandis EP. Prostate specific antigen in serum of women with breast cancer. Br J Cancer 1995; 72: 728-31.
18. Ferguson RA, Yu H, Kalyvas M, Zammit S, Diamandis EP. Ultrasensitive detection of prostate specific antigen by a new time resolved immunofluorometric assay and the Immulite immunochemiluminescent third generation assay: potential applications in prostate and breast cancers. Clin Chem (in press, 1995).
19. McCormack RT, Rittenhouse HG, Finlay JA, Sokoloff RL, Wang TJ, Wolfert RL, Lilja H, Oesterling JE. Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era. Urology 1995; 45: 729-44.
20. Diamandis EP, Yu H. New biological functions of prostate-specific antigen? J Clin Endocrinol Metab 1995; 80: 1515-7.
21. Lilja H, Bjork T, Abrahamsson P-A, Stenman UH, Shaw N, Dowell B, Oesterling JE, Pettersson K, Piironen T, Lovgren T. Improved seperation between normals, benign prostatic hyperplasia (BPH), and carcinoma of the prostate (CAP) by measuring free (F), complexed (C) and total concentrations (T) of prostate specific antigen. J Urol (Suppl) 1994; 151: 400A.